Particle.news

Download on the App Store

Senate Presses CDC Nominee Monarez on Vaccine Support and Public Health Reforms

Her hearing unveiled commitments to reinforce public trust through advanced infrastructure improvements alongside robust vaccine advocacy

Dr. Susan Monarez, President Donald Trump's choice to lead the CDC, testified before the Senate Health, Education, Labor, and Pensions Committee on Wednesday.
Susan Monarez, President Donald Trump's nominee to be director of the Centers for Disease Control and Prevention, arrives to testify before the Senate HELP Committee, at the Capitol in Washington, Wednesday, June 25, 2025. (AP Photo/J. Scott Applewhite)
Susan Monarez, President Donald Trump's nominee to be director of the Centers for Disease Control and Prevention, arrives to testify before the Senate HELP Committee, at the Capitol in Washington, Wednesday, June 25, 2025. (AP Photo/J. Scott Applewhite)
Susan Monarez, President Donald Trump's nominee to be director of the Centers for Disease Control and Prevention, arrives to testify before the Senate HELP Committee, at the Capitol in Washington, Wednesday, June 25, 2025. (AP Photo/J. Scott Applewhite)

Overview

  • Monarez affirmed that vaccines save lives and pledged to champion their widespread use if confirmed.
  • She offered to investigate HHS Secretary Kennedy’s decision to halt U.S. funding for the global vaccine alliance Gavi.
  • Senators probed her stance in light of Robert F. Kennedy Jr.’s recent removal of all 17 members of the CDC’s vaccine advisory committee.
  • Monarez outlined goals to modernize public health infrastructure and adopt rapid, evidence-based decision making to rebuild CDC credibility.
  • She has led the CDC as acting director since January and brings health expertise from roles in both government and the private sector under four administrations.